Delivery Order SPE2DB20D9331-SPE2DB22FL0D9
- Not listed
- This federal contract award, valued at $86,440.56, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4,557,549,804 units of the oncology medication ONCASPAR in 5 ML vials. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,531.40 firm fixed-price delivery order is for the supply of 4,566,744,841 units of the oncology medication ONCASPAR 3,750 UNIT/5 ML VIAL 5ML. This award is made under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to issue...
- This federal contract award is for the delivery of 3,750 units of the pharmaceutical drug ONCASPAR 5 ML Vial to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $99,062.80 firm fixed-price contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has an ultimate completion date of March 14, 2023 and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $82,930.72 delivery order is for 3,750 units of the oncology medication ONCASPAR in 5 ML vials. The award is under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 between DMS Pharmaceutical Group and the DLA, which enables the DLA to issue delivery orders for a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $43,220.28, is a firm fixed-price delivery order for the supply of 4,556,239,764 units of the oncology drug Oncaspar (pegaspargase) in 5 ml vials. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $86,440.56, is a firm fixed-price delivery order for 3,750 units of the oncology medication ONCASPAR 3,750 UNIT/5 ML VIAL 5ML. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $41,465.36, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for 4,555,808,568 units of the pharmaceutical product ONCASPAR 3,750 UNIT/5 ML VIAL 5ML, with a completion date of January 14, 2022. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $43,220.28, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for 4,556,804,083 units of the prescription drug ONCASPAR, a 3,750 unit/5 ml vial, with an ultimate completion date of April 21, 2022. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $43,220.28 firm fixed-price delivery order is for the supply of 4,556,804,056 units of the oncology medication ONCASPAR (pegaspargase) in 5 mL vials. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, which allows the DLA to issue...
- This federal contract award, valued at $41,465.36, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,555,808,561 units of the pharmaceutical product ONCASPAR, a 3,750 unit/5 mL vial. The contract is a firm fixed-price delivery order with a completion date of January 20, 2022, and is not associated with any set-aside designations. DMS...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB22FL0D9Delivery Order
This federal contract award, valued at $82,930.72, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,555,565,043 units of the oncology drug ONCASPAR in 5 ml vials. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $82.9k | 11/16/21 |